The Second International Conference on Screening for Lung Cancer
Location: Weill Medical College of Cornell University
1300 York Avenue, New York NY 10021
Friday, February 25, 2000 to Sunday, February 27, 2000.
Conference Agenda
| Friday, February 25th, 2000 | |
|---|---|
| Morning Plenary Session Location: Uris Auditorium | |
| 8:15-8:20 | Welcome - James P. Smith, Weill Medical College of Cornell University, New York |
| 8:20-8:30 | Summary of the First International Conference on Screening for Lung Cancer - Claudia I. Henschke, Weill Medical College of Cornell University, New York |
| 8:30-8:40 | Summary of the Workshop on " An European strategy for developing lung cancer molecular diagnostics in high-risk populations", John K. Field, Roy Castle International Center for Lung Cancer Research, United Kingdom |
| 8:40-8:50 | Summary of the NCI meeting on screening for lung cancer - Christine Berg, National Cancer Institute, Washington DC |
| 8:50-9:00 | Summary of the ACS/UICC meeting on surrogate endpoints - Robert Smith, American Cancer Society, Georgia |
| 9:00-9:10 | Mission of this conference - Claudia Henschke, Weill Medical College of Cornell University, New York |
| International Perspectives on Screening for Lung Cancer Moderator: Alvin Mushlin, Weill Medical College of Cornell University, New York | |
| 9:10-9:15 | Introductory Comments - Alvin Mushlin, Weill Medical College of Cornell University, New York |
| 9:15-9:25 | Cost of CT screening - Robert Clark, H. Lee Moffitt Cancer Center, Florida |
| 9:25-9:35 | Prospects for cost-effective CT screening - Deborah Marshall, Bayer Diagnostics, California |
| 9:35-9:50 | Baseline results - University of Muenster - Stephan Diederich, University of Muenster, Germany |
| 9:50-10:10 | Non-RCT Research Efforts - Claudia Henschke, Weill Medical College of Cornell University, New York |
| 10:10-10:30 | RCT Research Efforts - Robert Smith, American Cancer Society, Georgia |
| 10:30-10:45 | Coffee Break |
| Evolving Actions on Early Lung Cancer I: Advances in Screening and Diagnostic Techniques Moderator: Shusuke Sone, Shinshu University, Japan | |
| 10:45-11:00 | CT scanners - Stanley Fox, General Electric Corporation, Wisconsin |
| 11:00-11:15 | CT image processing - Anthony Reeves, Cornell University, New York |
| 11:15-11:30 | Image analysis of sputum and tissue sections - Stephen Lam and Branko Palcic, Vancouver General Hospital, Canada |
| 11:30-11:45 | Sputum sample processing - Steven Weiss, Bayer Diagnostics, New York |
| 11:45-12:00 | Detection of lymph node metastases - Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York |
| 12:00-1:00 | Lunch |
| Evolving Action on Early Lung Cancer II: Advances in Treatment of Stage IA Moderator: Nasser Altorki, Weill Medical College of Cornell University, New York | |
| 1:00-1:10 | Overview of treatment advances - Nasser Altorki, Weill Medical College of Cornell University, New York |
| 1:10-1:25 | Limited resection - Robert Ginsberg, Memorial Sloan Kettering Cancer Center, New York |
| 1:25-1:40 | Limited resection - Junji Yoshida, National Cancer Center East Hospital, Japan |
| 1:40-1:55 | Anti-angiogenic therapy - Roy Herbst, MD Anderson, Texas |
| 1:55-2:10 | Chemoprevention post resection - Andrew Dannenberg, Weill Medical College of Cornell University, New York |
| 2:10-2:25 | Chemotherapy - Paul Bunn, University of Colorado Cancer Center, Colorado |
| 2:25-2:45 | Assessment of the effectiveness of early treatment as compared with late treatment - Edmund Gehan, Vince Lombardi Cancer Center of Georgetown University, Washington DC |
| 2:45-3:15 | Coffee Break |
| Fundamentals of Study Design Moderators: Robert Smith, American Cancer Society, Georgia, and Nathaniel Berlin, Florida | |
| 3:15-3:30 | Criticisms of the non-RCT approach by RCT Advocates - Christine Berg, National Cancer Institute, Washington DC |
| 3:30-3:45 | Response by Non-RCT Advocates - Olli S. Miettinen, Claudia Henschke, David Yankelevitz |
| 3:45-4:00 | Criticisms of the non-RCT approach by RCT Advocates - Olli S. Miettinen, Claudia Henschke, David Yankelevitz |
| 4:00-4:15 | Response by Non-RCT Advocates - Christine Berg, National Cancer Institute, Washington DC |
| 4:15-5:30 | Discussion |
| Saturday, February 26, 2000 | |
| Subgroup Sessions Location: Weill Auditorium, 2nd floor | |
| 9:00-12:00 | Subgroup sessions: 1. Pooling of data 2. Evaluation of diagnostics in screening research 3. Evaluation of treatments in screening research 4. Quality assurance of imaging in screening research 5. Quality assurance in pathology in screening research |
| 12:00 - 1:30 | Lunch |
| 1:30-5:00 | Subgroup sessions |
| Sunday, February 27, 2000 | |
| Plenary Session Location: Weill Auditorium, 2nd floor | |
| 9:00 - 12:00 | Subgroup reports and discussion |
| 12:00 - 1:00 | Lunch |
| 1:00 - 4:00 | Development of consensus statements |
| 4:00-4:15 | Closing |
<< Back to The Second International Conference on Screening for Lung Cancer General Information
Management System
Stay Up-to-Date!
Sign up below to join our email list and receive notice of site updates and other I-ELCAP news.
Contact Us
Have questions? Contact us by email, telephone or mail.
Get Screened
Do you need to reach one of our member sites? Search our site locator, or skim our full list of member sites.
Thank You
I-ELCAP would like thank Idologic, Inc., for its donation of hosting and support services.